Regulation of Obesity by Antiangiogenic Herbal Medicines

Molecules. 2020 Oct 4;25(19):4549. doi: 10.3390/molecules25194549.

Abstract

Obesity is the result of an energy imbalance caused by an increased ratio of caloric intake to energy expenditure. In conjunction with obesity, related metabolic disorders, such as dyslipidemia, atherosclerosis, and type 2 diabetes, have become global health problems. Obesity progression is thought to be associated with angiogenesis and extracellular matrix (ECM) remodeling. Angiogenesis occurs in growing adult adipose tissues, which are similar to neoplastic tissues. Adipose tissue is highly vascularized, and each adipocyte is nourished by an extensive capillary network. Adipocytes produce proangiogenic factors, such as vascular endothelial growth factor A and fibroblast growth factor 2, which promote neovascularization within the adipose tissue. Furthermore, matrix metalloproteinases (MMPs), including MMP-2 and MMP-9, play important roles in adipose tissue development and microvessel maturation by modifying the ECM. Thus, modulation of angiogenesis and MMP activity provides a promising therapeutic approach for controlling human obesity and its related disorders. Over the past decade, there has been a great increase in the use of alternative treatments, such as herbal remedies, for these diseases. This review will focus on the role of angiogenesis in adipose tissue growth and the regulation of obesity by antiangiogenic herbal medicines.

Keywords: MMP; Melissa officinalis; Panax ginseng; adipose tissue growth; angiogenesis; medicinal herb; obesity.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Humans
  • Neovascularization, Physiologic / drug effects*
  • Obesity* / drug therapy
  • Obesity* / metabolism
  • Obesity* / pathology
  • Phytotherapy*
  • Plants, Medicinal*

Substances

  • Angiogenesis Inhibitors